Aeldra Pharmaceuticals Private Limited
U24100DL2014PTC264709ActivePrivate · Non-govt companyRoC-DelhiUnlisted
Last updated: 2026-06-08
67
Compliance Health · C · provisional
3 / 4 signals passed
Aeldra Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2014 and based in Delhi, India. Aeldra Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2022-23, the company reported revenue of ₹2.81 L and profit after tax of ₹8.0K. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Risk FlagsDirectors not yet extracted · awaiting MGT-7AGM 2050d ago · may be overdue
Revenue (latest FY)
₹2.81 L
2022-23
PAT (latest FY)
₹8.0K
Margin 2.9%
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
₹1.00 L
100% of authorized
Filings on Record
0
All current
Incorporated
2014
12 years old
State
Delhi
Sector
Pharmaceuticals & Chemicals
NIC 24100
Class
Private
Sub-category
Non-govt company
Authorized Capital
₹1.00 L
Paid-up Capital
₹1.00 L
100% utilized
Members
—
Last AGM
31 Dec 2020
2050d ago
Last Balance Sheet
31 Mar 2020
2325d ago
Latest Filing
—
Registered Email
g********(at)rediffmail.com
Registered Office
Office No-6 Second Floor E-13 Gali No- 20 Madhu Vihar IP Extension Delhi- 110092 NEW DELHI East Delhi DL 110092 IN
Quick facts
Registered office
Office No-6 Second Floor E-13 Gali No- 20 Madhu Vihar IP Extension Delhi- 110092 NEW DELHI East Delhi DL 110092 IN
NIC code
24100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
g********(at)rediffmail.com
Section
Pharmaceuticals & Chemicals
ROC
RoC-Delhi
Website
—
Class · sub-category
Private · Non-govt company
Incorporation · Last AGM
11 Feb 2014 · 31 Dec 2020
Directors
LockedAM
Arun Malhotra
Director6.2y · Mumbai · DIN 2094760
DR
Deepa Reddy
Whole-time Director2.8y · Mumbai · DIN 7020362
SG
Sneha Gupta
Whole-time Director2.1y · Pune · DIN 1532845
Get the full board of directors
Directors, DINs & appointment history for Aeldra Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +20d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +16d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Aeldra Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 542852462 | Kotak Mahindra Bank Ltd(Bank) | ₹7.43 Cr | 19 Sep 2020 | Satisfied |
| 173799499 | HDFC Bank Ltd(Bank) | ₹5.84 Cr | 04 Jul 2021 | Open |
| 289096948 | ICICI Bank Ltd(Bank) | ₹15.36 Cr | 04 Jul 2023 | Open |
| 670805879 | Axis Bank Ltd(Bank) | ₹6.97 Cr | 12 Mar 2023 | Open |
| 365421913 | State Bank of India(Bank) | ₹21.85 Cr | 12 Mar 2022 | Open |
| 326253671 | Kotak Mahindra Bank Ltd(Bank) | ₹22.72 Cr | 04 Jul 2023 | Open |
See registered charges & lenders
Charge IDs, lenders & amounts for Aeldra Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCARevenue (bars) vs PAT (line) by FY
Revenue PAT
| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2019-20 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2019-20 | 2017-18 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | -26.0% | -66.0% | -32.0% | |
| Profit after Tax2022-23 | +296.0% | -50.0% | -72.0% | |
| Net Worth2022-23 | -387.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +8.10% | — | — | +120.86% | — | |||
| 2016-17 | +2.99% | +22.52% | — | +5.62% | — | |||
| 2017-18 | +3.14% | +28.27% | — | +9.58% | — | |||
| 2019-20 | -34.13% | -68.23% | — | -28.71% | — | |||
| 2021-22 | +0.52% | +0.96% | +0.38% | +0.77% | 0.50 | |||
| 2022-23 | +2.87% | -56.85% | — | +6.16% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 1,68,38,517 | 79.39% |
| Institutional Investors | 1 | 7,84,590 | 3.70% |
| Public & Others | 15 | 35,85,483 | 16.91% |
See the full shareholding pattern
Promoter, institutional & public holding for Aeldra Pharmaceuticals Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
94 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
3rd quartile · P41
PAT (latest FY)
2nd quartile · P57
Employees
—
—
—
—
Paid-up capital
Bottom quartile · P1
Compliance Health
96
96
96
3rd quartile · P28
Events & timeline
201 Apr 2019
Mansi appointed as Director
11 Feb 2014
Company incorporated
Aeldra Pharmaceuticals Private Limited registered with RoC-Delhi; year 2014
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Aeldra Pharmaceuticals Private Limited
When was Aeldra Pharmaceuticals Private Limited incorporated?
Aeldra Pharmaceuticals Private Limited was incorporated in 2014 (around 11 Feb 2014). Its CIN is U24100DL2014PTC264709 and it is registered with RoC-Delhi.
Where is Aeldra Pharmaceuticals Private Limited located?
Aeldra Pharmaceuticals Private Limited is headquartered in Delhi, at: Office No-6 Second Floor E-13 Gali No- 20 Madhu Vihar IP Extension Delhi- 110092 NEW DELHI East Delhi DL 110092 IN .
What sector does Aeldra Pharmaceuticals Private Limited operate in?
Aeldra Pharmaceuticals Private Limited operates in the Pharmaceuticals & Chemicals sector (NIC code 24100), classified as Non-govt company.
Who are the directors of Aeldra Pharmaceuticals Private Limited?
Director details for Aeldra Pharmaceuticals Private Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Aeldra Pharmaceuticals Private Limited?
Aeldra Pharmaceuticals Private Limited has authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L.
Does Aeldra Pharmaceuticals Private Limited have any open charges?
Aeldra Pharmaceuticals Private Limited has no open MCA-registered charges on record.
What is Aeldra Pharmaceuticals Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Aeldra Pharmaceuticals Private Limited is 67/100 (grade C), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 3 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.